We are proud to be integrated with Caristo Diagnostics on our sites providing CT coronary angiography.
CaRi-Heart® analysis is a non-invasive #predictiveAI technology, providing individualised risk of fatal heart attack over 8 years.
Email [email protected] for more details 🫀
It’s a pleasure to announce our long-term partnership with Caristo Diagnostics.
See the full press release here: caristo.com/heart-lung-hea…
Fortunate unconcious gaffe during a recent talk 'Look after the 'little pubes' lining your endothelium' 🙈 😂😂. Prof John Deanfield once said 'Invest in your Arteries' same thing... #Glycocalyx
Venturi Cardiology Primary Healthcare Lifestyle Conference 2024….. Caristo Diagnostics Mamas A. Mamas Erin D. Michos, M.D. Dr. Martha Gulati ♥️🫀❤️🩹🇨🇦
Opening session at #ESCPrev2024 today highlighting LP(a) and new techniques to personalise cardiovascular risk #FAI #prevention Caristo Diagnostics Silence Therapeutics
Awesome time as visiting prof University of Oxford. Great meetings w Charis Antoniades #Profs Neubauer, Channon, Rider, Myerson, Raman Caristo Diagnostics. Best part: stay at Christ Church
Cleveland Clinic Heart, Vascular & Thoracic CCF Cardiology Fellows
Stephane N Hatem AFNET Charis Antoniades Sorbonne Université Institute of Pharmacology David Filgueiras Rama Maastricht University Patrick Ellinor Broad Institute Nadine IHU ICAN Stanley Nattel CNIC Preventicus Versorgungsmanagement University of Oxford Caristo Diagnostics IDOVEN TeraLab Siemens Healthineers And to finish off, our poster prize winner Ana Simon Chica from CNIC!
Many congratulations, amazing work.
#H2020MAESTRIA
AFNET
Great work by University of Bristol medical student Chinelo Afulukwe presenting #yeSCCT moderated poster from RUH Bath 🏥 in collaboration with Caristo Diagnostics at BSCI BSCCT ASM 2023. Do population risk scores or anatomical CTCA analysis predict risk?
📣 Caristo is honored to be recognized by Newsweek as one of the World's Best Digital Health Companies. 🔎 Read our press release to learn more - lnkd.in/dhDpcFVj #DigitalHealth #cardiotwitter #MedTwitter
📌Excellent presentation by Prof Charis Antoniades on the science underpinning our revolutionary CaRi-Heart technology🧡, at #ESCPrev2024 . Does coronary inflammation as measured by CaRi-Heart FAI-Score predict future cardiac events? Learn more 🔍lnkd.in/eWp6A_8U #MedTwitter
Proud to have supported Caristo Diagnostics's CaRi-Heart® analysis platform using artificial intelligence to predict #cardiovascular risk for coronary artery disease. A multi-site pilot across four hospitals has been funded by NHS England.
Case study: healthinnovationoxford.org/our-work/strat…
Happy #InternationalWomensDay At Caristo, we're dedicated to improving cardiovascular disease diagnosis by ensuring gender equality in healthcare. With CaRi-Heart® - our groundbreaking AI technology, we predict sex-specific cardiac risk. Read our blog bit.ly/3T6uAsh❤️
November is #NationalDiabetesMonth ! Find out how we supported Caristo Diagnostics with the development of their AI-enhanced technology to identify patients at risk of developing diabetes.
Read more in our case study: healthinnovationoxford.org/our-work/our-p…
Discover how #AI and #MachineLearning are transforming #cardiacCT #YesCCT at the #AI ML workshop on July 27! Our sponsors Caristo Diagnostics Cleerly Elucid and HeartFlow are leading the way. Get involved and join us!
Learn more: ow.ly/WxgC50P0MZE
💡“We are in an era of finding coronary disease, before we can see it...,” shared Prof. Nehal N. Mehta our esteemed Scientific Advisory Board member & Director of Inflammatory Risk and #PreventiveCardiology at the Hospital of University of Penn .Learn more lnkd.in/dAjjnbEN🫀
CT-first strategy the most effective path forward when evaluating stable chest pain cardiovascularbusiness.com/node/252021 #CTCA #digitalhealth American College of Cardiology Caristo Diagnostics via Cardiovascular Business
➡️Next Tuesday (5 March, 6pm, in the Meadow Suite) there will be a spotlight session on Cardiovascular Disease & Diagnostics
🗣️There will be multiple speakers including Cheerag Shirodaria,CDO of Caristo Diagnostics
Everyone is welcome!
Uni of Reading #biologicalsciences
#InTheClinic
~Median Technologies onboarding all academic sites for validation plan for iBiopsy® LCS CADe/CADx SaMD
~Endologix announces first patients treated with the DETOUR™ System
~Caristo Diagnostics deploys Cari-Heart imagining #technology in NHS pilot
Discover the new #cardiacdisease diagnostic technology currently piloting in the UK.
Caristo Diagnostics is deploying its latest CaRi-Heart® technology in NHS England hospitals as part of a new coronary artery disease management pathway pilot.
➡️ digitalinnovationeu.com/magazine/augus…
